ArticleMicroorganisms2024
Prevalence of Atypical Bacteria in Patients from Different Paediatric Age Groups Diagnosed with a Respiratory Disease.
Cesar Arellano-Arellano, Graciela Villeda-Gabriel, Francisco-Javier Prado-Galbarro, Paola Alejandra Barrientos González, Magali Reyes Apodaca, Uriel Gomez-Ramirez, Dina Villanueva García, Araceli Contreras-Rodríguez, Ma Guadalupe Aguilera-Arreola, María Isabel Franco Hernández and 3 more
Abstract read
In one paragraphArticle in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Cesar Arellano-ArellanoLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Graciela Villeda-GabrielDepartamento de Inmunología e Infectología, Instituto Nacional de Perinatología "Isidro Espinosa de Los Reyes", Mexico City 11000, Mexico.
Francisco-Javier Prado-GalbarroDirección de Investigación, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-1474-5228 Paola Alejandra Barrientos GonzálezDepartamento de Neonatología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Magali Reyes ApodacaUnidad de Investigación y Diagnóstico en Nefrología y Metabolismo Mineral Óseo, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0001-6211-7843 Uriel Gomez-RamirezLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0003-2223-226X Dina Villanueva GarcíaDepartamento de Neonatología, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Araceli Contreras-RodríguezDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.
Ma Guadalupe Aguilera-ArreolaDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City 11350, Mexico.
María Isabel Franco HernándezLaboratorio Clínico, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Israel Parra-OrtegaLaboratorio Clínico, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-7195-1749 Alma Lidia Olivares-CervantesLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.
Norma Velázquez-GuadarramaLaboratorio de Investigación en Microbiología y Resistencia Antimicrobiana, Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0002-3620-7260 Funding
Federal founds at the Hospital Infantil de México Federico 480 Gómez HIM/2017/110 SSA. 1434SIP 20164883, 20241088, 20240514
6 · The paper itselfAbstract
Atypical bacterial pathogens present the ability to induce pulmonary damage. At present, there are no available phenotypic diagnosis tests that achieve up to 100% reliability. Therefore, clinicians must utilise molecular techniques for the detection and identification of these pathogens. The main objective of this research was to evaluate the prevalence of atypical bacteria in paediatric patients from different age groups. A total of 609 clinical samples were collected from paediatric patients who presented with an adverse respiratory condition during the period from March 2021 to February 2024. DNA was extracted from the samples, and end-point PCR was performed to detect atypical bacteria. Statistical analyses were performed to evaluate the bacterial prevalence and assess clinical data from newborns and mothers that could be related to RDS. A total of 139 patients exhibited at least one atypical organism (22.82%).
Indexed as
atypical bacteriaend-point PCRmixed infectionspneumoniaeprevalenceRDS
Identifiers
PMID39597717
PMCPMC11596979
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390